IGF1R and ovarian carcinoma: miR-133a has also been implicated as an inhibitor of vascular smooth muscle [22] and ovarian cancer [23] cell proliferation, through the inhibition of insulin-like growth factor receptor 1 (IGF-1R) [GenBank: NM_010513], which is a potent stimulator of cardiomyocyte proliferation [24, 25].